- Home
- XNCR vs ACEL Comparison
XNCR vs ACEL Comparison
Compare XNCR & ACEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XNCR | ACEL |
|---|---|---|
| Founded | 1997 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2013 | 2017 |
Fundamental Metrics
Financial Performance| Metric | XNCR | ACEL |
|---|---|---|
| Price | $19.84 | $12.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $22.33 | $14.67 |
| AVG Volume (30 Days) | ★ 1.0M | 251.1K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.36 | 46.34 |
| EPS | N/A | ★ 0.32 |
| Revenue | ★ $125,576,000.00 | N/A |
| Revenue This Year | N/A | $7.07 |
| Revenue Next Year | $4.80 | $2.81 |
| P/E Ratio | ★ N/A | $71.53 |
| Revenue Growth | ★ 13.65 | N/A |
| 52 Week Low | $6.92 | $9.55 |
| 52 Week High | $21.76 | $14.00 |
Technical Indicators
Market Signals| Indicator | XNCR | ACEL |
|---|---|---|
| Relative Strength Index (RSI) | 62.00 | 54.84 |
| Support Level | $11.20 | $10.79 |
| Resistance Level | $21.26 | $12.55 |
| Average True Range (ATR) | 1.59 | 0.32 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 73.60 | 70.09 |
Price Performance
Historical ComparisonAbout XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.
About ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.